BackAlterity Therapeutics Overview

Alterity Therapeutics Selling, General & Admin

Selling, General & Admin expenses for ATHE.

Quarterly SG&A Expenses

$5.06M
↑ 205.84% YoY

As of Dec 31, 2025

Annual SG&A Expenses (TTM)

$10.54M
↑ 123.87% YoY

Trailing 12 months ending Dec 31, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin